Antimicrobial Resistance: Identifying the Major Conflicts of Interest and Way Forward
Samridhi Sharma1, Kemesha Govender1, Kiran Nagaraju1,2, Pratik Chhetri1,3, Thandiwe Menze4, Sunitha C Srinivas1★★ Corresponding author
- 1Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA.
- 2Department of Pharmacy Practice, Visveswarapura Institute of Pharmaceutical Sciences, Bengaluru, Karnataka, INDIA.
- 3LMIC Chapter Coordinator, Universities Allied for Essential Medicines (UAEM), California, USA.
- 4Principle Faculty Librarian: Science and Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA.
CORRESPONDENCE
Sunitha C Srinivas
Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA.
Volume 10, Issue 2 · pp. 69–77 · PUBLISHED · DOI: 10.5530/ijopp.10.2.16
ABSTRACT
“We find ourselves on the brink of a post-antibiotic era” – Department of Health Republic of South Africa, 2015.1 According to the World Health Organisation (WHO), antimicrobial resistance (AMR) is a global threat to public health.2 AMR causes around 700 000 deaths every year, and is projected to lead to 10 million deaths annually by 2050.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sharma, S., Govender, K., Nagaraju, K., Chhetri, P., Menze, T., & Srinivas, S. C. (). Antimicrobial Resistance: Identifying the Major Conflicts of Interest and Way Forward. Indian Journal of Pharmacy Practice, 10(2), 69–77. https://doi.org/10.5530/ijopp.10.2.16
